About Q BioMed, Inc.

Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. Its products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.68$ per share.

The book value per share is -0.36$

Q BioMed, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -8M - -10M -0.68 - - 14M -0.36 -5M - -5M